Aroa Biosurgery Limited

Informe acción ASX:ARX

Capitalización de mercado: AU$225.9m

Aroa Biosurgery Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Brian Ward

Chief Executive Officer (CEO)

NZ$1.1m

Compensación total

Porcentaje del salario del CEO54.1%
Permanencia del CEO17.2yrs
Participación del CEO9.6%
Permanencia media de la dirección3.6yrs
Promedio de permanencia en la Junta Directiva9.8yrs

Actualizaciones recientes de la dirección

Recent updates

We're Not Worried About Aroa Biosurgery's (ASX:ARX) Cash Burn

Nov 13
We're Not Worried About Aroa Biosurgery's (ASX:ARX) Cash Burn

Take Care Before Jumping Onto Aroa Biosurgery Limited (ASX:ARX) Even Though It's 29% Cheaper

Aug 22
Take Care Before Jumping Onto Aroa Biosurgery Limited (ASX:ARX) Even Though It's 29% Cheaper

Investors Aren't Entirely Convinced By Aroa Biosurgery Limited's (ASX:ARX) Revenues

Jun 12
Investors Aren't Entirely Convinced By Aroa Biosurgery Limited's (ASX:ARX) Revenues

Here's Why We're Not At All Concerned With Aroa Biosurgery's (ASX:ARX) Cash Burn Situation

Mar 25
Here's Why We're Not At All Concerned With Aroa Biosurgery's (ASX:ARX) Cash Burn Situation

Why Investors Shouldn't Be Surprised By Aroa Biosurgery Limited's (ASX:ARX) 25% Share Price Plunge

Jan 30
Why Investors Shouldn't Be Surprised By Aroa Biosurgery Limited's (ASX:ARX) 25% Share Price Plunge

Aroa Biosurgery Limited's (ASX:ARX) Revenues Are Not Doing Enough For Some Investors

Nov 14
Aroa Biosurgery Limited's (ASX:ARX) Revenues Are Not Doing Enough For Some Investors

Industry Analysts Just Made A Captivating Upgrade To Their Aroa Biosurgery Limited (ASX:ARX) Revenue Forecasts

Nov 02
Industry Analysts Just Made A Captivating Upgrade To Their Aroa Biosurgery Limited (ASX:ARX) Revenue Forecasts

Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 50% Above Its Share Price

Oct 25
Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 50% Above Its Share Price

We Think Aroa Biosurgery (ASX:ARX) Can Easily Afford To Drive Business Growth

May 13
We Think Aroa Biosurgery (ASX:ARX) Can Easily Afford To Drive Business Growth

Here's What Analysts Are Forecasting For Aroa Biosurgery Limited (ASX:ARX) After Its Annual Results

May 26
Here's What Analysts Are Forecasting For Aroa Biosurgery Limited (ASX:ARX) After Its Annual Results

An Intrinsic Calculation For Aroa Biosurgery Limited (ASX:ARX) Suggests It's 27% Undervalued

Mar 22
An Intrinsic Calculation For Aroa Biosurgery Limited (ASX:ARX) Suggests It's 27% Undervalued

Do Institutions Own Aroa Biosurgery Limited (ASX:ARX) Shares?

Feb 24
Do Institutions Own Aroa Biosurgery Limited (ASX:ARX) Shares?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Aroa Biosurgery Limited (ASX:ARX)

Feb 24
Don't Ignore The Fact That This Insider Just Sold Some Shares In Aroa Biosurgery Limited (ASX:ARX)

Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 44% Above Its Share Price

Dec 16
Aroa Biosurgery Limited's (ASX:ARX) Intrinsic Value Is Potentially 44% Above Its Share Price

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Brian Ward en comparación con los beneficios de Aroa Biosurgery?
FechaCompensación totalSalarioIngresos de la empresa
Mar 31 2024NZ$1mNZ$583k

-NZ$11m

Dec 31 2023n/an/a

-NZ$9m

Sep 30 2023n/an/a

-NZ$8m

Jun 30 2023n/an/a

-NZ$4m

Mar 31 2023NZ$1mNZ$552k

-NZ$396k

Dec 31 2022n/an/a

-NZ$1m

Sep 30 2022n/an/a

-NZ$2m

Jun 30 2022n/an/a

-NZ$5m

Mar 31 2022NZ$1mNZ$542k

-NZ$8m

Dec 31 2021n/an/a

-NZ$10m

Sep 30 2021n/an/a

-NZ$11m

Jun 30 2021n/an/a

-NZ$15m

Mar 31 2021NZ$2mNZ$483k

-NZ$19m

Compensación vs. Mercado: La compensación total de Brian($USD628.82K) está por encima de la media de empresas de tamaño similar en el mercado Australian ($USD297.98K).

Compensación vs. Ingresos: La compensación de Brian ha sido consistente con los resultados de la empresa en el último año.


CEO

Brian Ward

17.2yrs

Permanencia

NZ$1,078,619

Compensación

Dr. Brian Ward, B.V.Sc, MBA(dist) has been Executive Director at Aroa Biosurgery Limited since September 21, 2007 and serves as its Managing Director and Chief Executive Officer. He has founded Aroa Biosur...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Brian Ward
Founderno dataNZ$1.08m9.6%
A$ 21.7m
James Agnew
CFO & Joint Company Secretary4.8yrsNZ$627.01ksin datos
Rod Stanley
Chief Technology Officerless than a yearsin datossin datos
Barnaby May
Chief Scientific Officer2.9yrssin datos0.95%
A$ 2.1m
Neetha Alex-Kumar
General Counselno datasin datossin datos
Frazer Murray
Director of Global Marketing & Strategyno datasin datossin datos
Yasmin Winchester
Vice President of Qualityno datasin datossin datos
Tracy Weimar
Joint Company Secretary4.3yrssin datossin datos
Adam Young
Vice President of Medical Affairsno datasin datossin datos

3.6yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de ARX se considera experimentado (3.6 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Brian Ward
Founder17.2yrsNZ$1.08m9.6%
A$ 21.7m
James McLean
Independent Non-Executive Chairperson13.3yrsNZ$212.19k0.82%
A$ 1.9m
John Diddams
Independent Non-Executive Director5yrsNZ$159.36k0.35%
A$ 781.1k
John Pinion
Independent Non-Executive Director9.8yrsNZ$187.52k0.14%
A$ 309.5k
Philip McCaw
Non-Executive Director16.7yrsNZ$130.68k5.68%
A$ 12.8m
Catherine Mohr
Independent Non-Executive Director2yrsNZ$178.02k0.13%
A$ 285.8k
Darla Hutton
Independent Non-Executive Directorless than a yearNZ$4.73k0.041%
A$ 91.8k

9.8yrs

Permanencia media

58yo

Promedio de edad

Junta con experiencia: La junta directiva de ARX se considera experimentada (9.8 años de antigüedad promedio).